r.restrepo

TL2 · Tours

Contributes reviews on supplier material. Based in Tours.

Joined 5 March 2025 · last posted 22h

79Posts here

1Topics

1Solutions

486Likes received

674Likes given

19Badges

162Days visited

2.7kPosts read

Recent activity

Full stream

Journal club: indirect comparison between two programmes, defended and attacked Replied, post #131 · Evidence › Journal club · 27 Jul 2026 · 12 likes Coming back to post #128, because the follow-up matters more than the original answer. An hour is enough for one paper read properly and not enough for two read partly.…
Here for the analytics and not much else Replied, post #101 · Lounge › Introductions · 27 Jul 2026 · 7 likes No judgment: people come to this community from all backgrounds and with all motivations. Introductions are for getting to know each other, not for evaluation.
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #126 · Sourcing › Independent verification · 26 Jul 2026 · 0 likes Taking post #125 at face value and following it one step further. The record shows what was measured. Everything beyond that is inference and this site tries to keep…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #121 · Analytics › Home & field testing · 24 Jul 2026 · 10 likes Appreciated. The plain phrasing does more work here than a longer post would.
Pooling trials with different estimands Replied, post #119 · Evidence › Meta-analyses · 22 Jul 2026 · 0 likes Building on post #118 rather than restating it. Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #50 · Pharmacology › Receptor biology · 20 Jul 2026 · 10 likes Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat oxidation. The mechanism is distinct from GLP-1 and GIP…
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #70 · Practice › Administration · 14 Jul 2026 · 1 like Post #68 and I disagree about the size of the effect, not about the direction. The practical version of completing a dose is three sentences long. The rigorous version…
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #30 · Practice › Interactions · 10 Jul 2026 · 26 likes I read post #26 twice before replying, because I had assumed the opposite. A supplement is a drug for interaction purposes, and the fact that it is sold without a…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #43 · Evidence › Journal club · 9 Jul 2026 · 29 likes Narrowing post #42, because the general version has more than one answer. Two people in this thread mean different things by SUSTAIN 6 and are disagreeing about the…
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #63 · Analytics › Method validation · 22 Jun 2026 · 0 likes Post #61 answers the question as asked. The question underneath it is different. Reporting a result to more decimal places than the method's precision supports is a…
Does dual agonism explain the effect size, or is it dose? Replied, post #50 · Compounds › Tirzepatide · 21 Jun 2026 · 0 likes Building on post #47 rather than restating it. The published pharmacokinetics show dose proportionality across the studied range, which means dose arithmetic behaves…
How shortages have affected compounding permissions — does this still hold? Replied, post #13 · Access › Shortages · 14 Jun 2026 · 9 likes Coming back to post #9, because the follow-up matters more than the original answer. Shortages end and the notices are updated. Checking the current notice takes a…